Treatment of chronic myeloid leukemia in blast crisis

被引：33

作者：

Hehlmann, R. ^{[1
]}

Saussele, S. ^{[1
]}

机构：

[1] Heidelberg Univ, Med Fak Mannheim, D-6800 Mannheim, Germany

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷 / 12期

关键词：

D O I：

10.3324/haematol.2008.001214

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1765 / 1769

页数：5

共 34 条

[11] Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia [J].

Giles, Francis J. ;

DeAngeloc, Daniel J. ;

Baccaran, Michele ;

Deininger, Michael ;

Guilhot, Francois ;

Hughes, Timothy ;

Mauro, Michael ;

Radich, Jerald ;

Ottmann, Oliver ;

Cortes, Jorge .

SEMINARS IN ONCOLOGY, 2008, 35 (01) :S1-S17

[12]

Giles J, 2008, HAEMATOL-HEMATOL J, V93, P46

[13]

Gratwohl A, 2006, HAEMATOLOGICA, V91, P513

[14] Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia [J].

Hehlmann, Ruediger ;

Berger, Ute ;

Pfirrmann, Markus ;

Heimpel, Hermann ;

Hochhaus, Andreas ;

Hasford, Joerg ;

Kolb, Hans-Jochem ;

Lahaye, Tanja ;

Maywald, Ole ;

Reiter, Andreas ;

Hossfeld, Dieter K. ;

Huber, Christoph ;

Loeffler, Helmut ;

Pralle, Hans ;

Queisser, Wolfgang ;

Tobler, Andreas ;

Nerl, Christoph ;

Solenthaler, Max ;

Goebeler, Mariele E. ;

Griesshammer, Martin ;

Fischer, Thomas ;

Kremers, Stephan ;

Eimermacher, Hartmut ;

Pfreundschuh, Michael ;

Hirschmann, Wolf-Dietrich ;

Lechner, Klaus ;

Wassmann, Barbara ;

Falge, Christiane ;

Kirchner, Hartmut H. ;

Gratwohl, Alois .

BLOOD, 2007, 109 (11) :4686-4692

[15] Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML [J].

Jamieson, CHM ;

Ailles, LE ;

Dylla, SJ ;

Muijtjens, M ;

Jones, C ;

Zehnder, JL ;

Gotlib, J ;

Li, K ;

Manz, MG ;

Keating, A ;

Sawyers, CL ;

Weissman, IL .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (07) :657-667

[16] Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL [J].

Kantarjian, Hagop ;

Giles, Francis ;

Wunderle, Lydia ;

Bhalla, Kapil ;

O'Brien, Susan ;

Wassmann, Barbara ;

Tanaka, Chiaki ;

Manley, Paul ;

Rae, Patricia ;

Mietlowski, William ;

Bochinski, Kathy ;

Hochhaus, Andreas ;

Griffin, James D. ;

Hoelzer, Dieter ;

Albitar, Maher ;

Dugan, Margaret ;

Cortes, Jorge ;

Alland, Leila ;

Ottmann, Oliver G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24) :2542-2551

[17] Imatinib mesylate (ST1571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase [J].

Kantarjian, HM ;

Cortes, J ;

O'Brien, S ;

Giles, FJ ;

Albitar, M ;

Rios, MB ;

Shan, JQ ;

Faderl, S ;

Garcia-Manero, G ;

Thomas, DA ;

Resta, D ;

Talpaz, M .

BLOOD, 2002, 99 (10) :3547-3553

[18] CHARACTERISTICS OF TERMINAL PHASE OF CHRONIC GRANULOCYTIC LEUKEMIA [J].

KARANAS, A ;

SILVER, RT .

BLOOD, 1968, 32 (03) :445-&

[19] BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance [J].

Koptyra, Mateusz ;

Falinski, Rafal ;

Nowicki, Michal O. ;

Stoklosa, Tomasz ;

Majsterek, Ireneusz ;

Nieborowska-Skorska, Margaret ;

Blasiak, Janusz ;

Skorski, Tomasz .

BLOOD, 2006, 108 (01) :319-327

[20] Chronic myeloid leukaemia as a model of disease evolution in human cancer [J].

Melo, Junia V. ;

Barnes, David J. .

NATURE REVIEWS CANCER, 2007, 7 (06) :441-453

← 1 2 3 4 →